SOVREN Advanced Textiles  ·  Rubyvale, Queensland, Australia

The dressing that listens.
The textile that heals.

A bio-transductive composite textile platform combining real-time wound intelligence and pH-gated antimicrobial governance — delivering medical-grade performance from a single rGO scaffold architecture, at roughly a third of the silver a conventional fibre would need.

15
Provisional Patents Filed
≈⅓
the silver of a conventional fibre
5
Commercial Paths
2026
IP Filed & Protected

The Platform

One architecture.
Five commercial paths.

A single reduced graphene oxide scaffold enables wound intelligence, antimicrobial governance, and field-deployable diagnostics — with an OEM licensing pathway that lets established manufacturers access the platform without capital risk.

01
Defence & Clinical
Galvanex™ / Active Shield™

Bio-transductive wound dressing with real-time pH sensing. Silver Wand diagnostic instrument. Hospital Constellation network. Field Mode for forward operating environments. Exit targets: Teijin, Noble Biomaterials, Asahi Kasei.

02
Wound Care
Colorimetric Wound Indicator

Device-free wound status. BTB/PR dual-dye chemistry produces a visible Green/Amber/Red output without any instrument. Home triage, pharmacy, and veterinary channels. Lowest regulatory resistance route to first revenue.

03
Consumer & Veterinary
Active Shield™ Home & Vet Range

Device-free colorimetric wound care for home triage, pharmacy OTC, and veterinary applications. BTB/PR dual-dye dressing produces a visible Green/Amber/Red wound status reading at the bedside — no instrument, no training, no network required. Large animal and equine wound care. Lowest regulatory resistance route to first commercial revenue.

04
Military & Field
SOVREN™ Field Kit

Complete soldier system — ground to head. Earth Tack™ grounding interface, Galvanex™ sock and briefs, Active Shield™ field dressing, Silver Wand Field Mode. Three-second traffic-light wound status at the point of injury without laboratory infrastructure or network connectivity. Australian Defence Force procurement pathway via Ventia Group. View the full system ↗

05
OEM Licensing
rGO Scaffold Licensing

License the core rGO textile chemistry and manufacturing process directly to established technical textile manufacturers — no product risk, no inventory, no distribution overhead. Royalty revenue from existing production capacity at scale. Target licensees: Freudenberg Performance Materials, Toray, PrimaLoft, Shawmut. The fastest route to institutional validation converting directly into recurring revenue.

The Technology

The advantage that
changes everything.

To reach full medical-grade conductivity with silver alone, our analysis indicates a conventional fibre would need to carry on the order of 30%+ silver by weight — roughly three times the silver content per kilogram, and impractical at scale. SOVREN's 1.5 wt% rGO scaffold is designed to reach the same performance target at about 10 wt% silver, the rGO carrying the conductive network that bulk silver would otherwise provide. The advantage is structural — a property of the architecture, not the silver price.

Silver-only — 30%+ Ag
~3×
the silver per kg, to match (our analysis)
Galvanex™ — 1.5% rGO + ~10% Ag
baseline silver content (target)
Same performance, ≈⅓ the silver
Performance is the advantage; favourable economics follow. Figures are design targets pending Gate 1 validation.
15 provisional patents filed — Feb to May 2026
Gate 1 validation pending — UniSQ Centre for Future Materials, Toowoomba
All performance claims are predictions pending institutional validation
IP & Validation Roadmap
Feb – May 2026
15 Provisionals Filed
Priority dates secured across all five technology stacks.
2026 Q3
Gate 1 Validation
UniSQ Centre for Future Materials — conductivity, antimicrobial efficacy, structural integrity.
Early 2027
PCT Filing Window
12-month provisional deadline. National phase entry across AU, US, EU, JP priority jurisdictions.
2027
First Licensing Conversation
Validated data package enables formal OEM licensing and strategic investor engagement.
2027 – 2028
Prototype & Clinical Pathway
First clinical-grade prototype run. TGA regulatory strategy. Defence procurement engagement.

Nano-Architecture

The fibre, magnified.

At nanoscale, what appears to be fabric reveals a precisely engineered composite — a bamboo-derived cellulose non-woven substrate enveloped in a hexagonal reduced graphene oxide lattice, with silver nanoparticles anchored at each carboxylate coordination site through proprietary molecular sequestration.

Gr / AgNP Nano-fibre
rGO hybrid composite · interactive cross-section
rGO lattice Ag nanoparticles coordination bonds ⊕ / ⊖ charges
drag · scroll to zoom
Fibre architecture
rGO hexagonal lattice

A bamboo-derived cellulose non-woven substrate is enveloped in a single-atom-thick reduced graphene oxide mesh arranged in the honeycomb geometry that gives graphene its extraordinary conductivity and tensile strength. The lattice acts as both structural scaffold and signal conduit.

Nano-anchoring
Molecular sequestration

Silver nanoparticles (AgNP) are anchored at each carboxylate coordination site through a proprietary nano-anchoring process. Differential surface charges (⊕/⊖) drive and maintain molecular sequestration — locking particles without adhesives or mechanical fixings.

Mechanism
Bio-transductive sensing

The AgNP/rGO composite responds to physiological signals — pressure, perspiration, bioelectrical potentials and molecular biomarkers — converting them to measurable electrical signals. There are no embedded electronics; the textile is the sensor.

Application
Force protection & medical monitoring

Designed for seamless integration into standard military and first-responder kit, the platform enables continuous physiological surveillance at zero additional burden or signature — the same architecture supports civilian medical-grade monitoring and triage.

pH GATE OPEN pH > 7.4 BAMBOO CELLULOSE CORE rGO LATTICE ZONE GALVANEX™ rGO FIBRE — SCHEMATIC AXIAL CROSS-SECTION
rGO Lattice
Hexagonal graphene scaffold

Single-atom-thick honeycomb mesh of reduced graphene oxide envelopes the fibre core — simultaneously a structural scaffold, conductivity highway, and molecular anchor framework.

AgNP Clusters
Snowflake geometry AgNP

Silver nanoparticle clusters at lattice junctions adopt a dendritic snowflake geometry — maximising active surface area for antimicrobial release while maintaining molecular sequestration at carboxylate coordination sites.

Carboxylate Bonds
–COO⁻ / –COOH anchors

Carboxylate functional groups (–COOH / –COO⁻) provide the coordination bridge between the rGO surface and AgNP clusters, enabling pH-responsive charge switching and irreversible particle anchoring.

pH Gate
Ion-selective permeation gate

At the outer membrane boundary, a pH-sensitive ion gate governs silver ion egress. Above pH 7.4 (healing wound) the gate opens; below 7.4 (infection present) the gate activates full antimicrobial release.

pH GATE: OPEN

Ground to head.
One architecture.

The SOVREN™ Field Kit is a complete soldier system — six layers of Galvanex™ rGO governance from the Earth Tack™ ground interface to the helmet liner. No electronics. No battery. No additional RF signature. The same chemistry that governs a wound dressing governs the plantar surface, the gusset, the base layer, and the cranial liner simultaneously.

01
Earth
Earth Tack™ ground interface. <1Ω at heel-strike.
02
Sock
Galvanex™ Ag plantar governance. pH-gated TIR. 34 active cycles.
03
Brief
Sovereign Briefs™ gusset & brief. Colorimetric indicator. Galvanic Overlap bridge.
04
Wound
Active Shield™ field dressing. Silver Wand Field Mode. 3-second traffic-light.
05
Base Layer
Galvanex™ shirt. Somatic Data Bus. EMF shielding. <10Ω total system.
06
Helmet
Galvanex™ liner. Cranial antimicrobial. ESD protection for head-worn electronics.
<10Ω
Earth to cranium
34
Active governance cycles
≈⅓
the silver of a conventional fibre
43
Days to first delivery
View the full system ↗
galvanex.com.au  ·  AU 2026901583  ·  AU 2026901846

Intellectual Property

Fifteen applications.
One constellation.

All 15 applications are Australian provisional filings — not yet examined or granted. Priority dates are real and legally significant. The view below highlights the core platform applications. Freedom-to-operate: preliminary AI-assisted prior art review only, May 2026. Formal legal opinion recommended before commercial launch.

Core rGO Platform 3 applications
AU 2026902065
Core IP — 1.5% rGO Arbitrage

Percolation threshold, galvanic self-repair, AgNP snowflake geometry. The foundational claim.

AU 2026904327
Trifecta Architecture

Interchangeable frame and active insert system for sequential therapeutic deployment.

AU 2026901835
31.4% Ag-Nylon Benchmark

Owned analytical benchmark — the silver loading a conventional fibre would need to match Galvanex performance (SOVREN analysis).

Clinical Wound Stack 4 applications
AU 2026902002
Bio-Transductive Wound Dressing

pH-gated TIR, 330 Ohm Sepsis Gate, N_max = 34 cycles.

AU 2026902003
Silver Wand Diagnostic System

Three-zone Sepsis Gate logic, Clinical and Field Mode, NFC integration.

AU 2026902046
Constellation Hospital Network

32-unit ward hub, Outbreak Risk Index, HL7 FHIR R4.

AU 2026903265
Dual-Tip Interface

Concurrent Ohmic and potentiometric sensing. Ionic decoupling.

Colorimetric Platform 1 application
AU 2026903740
Colorimetric Wound Indicator

Device-free visual wound pH monitoring. BTB/PR dual-dye.

Foundation & Shielding Stack 4 applications
AU 2026901583
Modular Bio-Electrical Grounding — Footwear

Military sock foundation patent.

AU 2026901640
Unified Zonal Bio-Electrical Shielding

Zonal EMI shielding architecture.

AU 2026901672
High-Density Noble Metal Textile Matrix

Percolation phase conductivity.

AU 2026901846
Universal Shield / Somatic Data Bus

Galvanic mimicry and data bus architecture.

Contact

Opening conversations
with the right partners.

SOVREN Advanced Textiles is a sole trader operation at pre-seed stage, with 15 provisional patents filed and institutional validation pending at UniSQ. We are actively seeking three kinds of conversation.

Validation Partners

Materials science institutions and testing laboratories able to provide independent Gate 1 conductivity and antimicrobial validation. We offer co-authorship and acknowledged IP contribution.

Strategic Investors

Pre-seed capital to fund UniSQ validation, PCT filing across priority jurisdictions, and first prototype production run. Seeking patient capital aligned with deep-tech timelines and defence-dual-use exit pathways.

OEM & Commercial Partners

Established technical textile manufacturers seeking licensed access to the rGO scaffold platform. No joint venture required — a clean licensing arrangement with royalty structure tailored to production volume.

Founder
Adam W. Bell
ABN
67 996 925 236
Primary Email
Phone
+61 457 272 286
Location
Rubyvale, Queensland, Australia
Domains

All SOVREN Advanced Textiles patent applications are Australian provisional filings — not yet examined or granted. All performance specifications are materials science predictions based on published literature and patent specifications. Independent institutional validation is pending at UniSQ Centre for Future Materials, Toowoomba. Freedom-to-operate assessments are AI-assisted and preliminary — formal legal opinion recommended before commercial launch. Active Shield™, Galvanex™, Silver Wand™, and SOVREN™ are trademarks of Adam W. Bell. May 2026.